BridgeBio Pharma, Inc.
BBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001743881
In the last 90 days, BridgeBio Pharma, Inc. insiders filed 0 open-market purchases and 5 sales; 475 institutions reported holding it in 13F filings for Q2 2026, worth $14.4B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q2 2025
Institutional positions in BridgeBio Pharma, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 359
- +58 vs. Q1 2025
- Shares held
- 188.8M
- +2.42M (+1.3%) vs. Q1 2025
- Total value
- $8.15B
- +$1.71B (+26.5%) vs. Q1 2025
- New holders
- 92
- 136 more added
- Sold out
- 34
- 105 more reduced
3 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 475 | $14.4B |
| Q1 2026 | 462 | $14.4B |
| Q4 2025 | 435 | $14.4B |
| Q3 2025 | 392 | $9.62B |
| Q2 2025 | 359 | $8.15B |
| Q1 2025 | 304 | $6.45B |
| Q4 2024 | 263 | $4.85B |
| Q3 2024 | 254 | $4.39B |
| Q2 2024 | 251 | $4.43B |
| Q1 2024 | 244 | $5.31B |
| Q4 2023 | 247 | $6.69B |
| Q3 2023 | 221 | $4.24B |
| Q2 2023 | 197 | $2.58B |
| Q1 2023 | 213 | $2.53B |
| Q4 2022 | 179 | $1.10B |
| Q3 2022 | 181 | $1.44B |
| Q2 2022 | 165 | $1.28B |
| Q1 2022 | 179 | $1.45B |
| Q4 2021 | 195 | $2.37B |
| Q3 2021 | 212 | $6.56B |
| Q2 2021 | 201 | $8.70B |
| Q1 2021 | 199 | $8.69B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding BridgeBio Pharma, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| PFM Health Sciences, LP | 521,793 | $22.5M | 1.95% | −386,342−42.5% | Reduced |
| Frontier Capital Management Co LLC | 535,763 | $23.1M | 0.21% | −233,538−30.4% | Reduced |
| Bank of New York Mellon Corp | 548,207 | $23.7M | 0.00% | +64,532+13.3% | Added |
| First Turn Management, LLC | 551,684 | $23.8M | 4.44% | −105,015−16.0% | Reduced |
| Qube Research & Technologies Ltd | 564,216 | $24.4M | 0.03% | −196,258−25.8% | Reduced |
| Primecap Management Co | 588,710 | $25.4M | 0.02% | −324,490−35.5% | Reduced |
| Millennium Management LLC | 620,458 | $26.8M | 0.02% | +380,538+158.6% | Added |
| Susquehanna International Group, LLP | 634,573 | $27.4M | 0.04% | −105,131−14.2% | Reduced |
| Emerald Mutual Fund Advisers Trust | 645,745 | $27.9M | 1.70% | −78,609−10.9% | Reduced |
| UBS Asset Management Americas Inc | 704,357 | $30.4M | 0.01% | +99,411+16.4% | Added |
| Panagora Asset Management Inc | 713,491 | $30.8M | 0.14% | +97,239+15.8% | Added |
| Summit Partners Public Asset Management, LLC | 757,745 | $32.7M | 1.28% | −371,847−32.9% | Reduced |
| Ameriprise Financial Inc | 787,044 | $34.0M | 0.01% | −254,891−24.5% | Reduced |
| Franklin Resources Inc | 821,405 | $35.5M | 0.01% | +482,149+142.1% | Added |
| Deep Track Capital, LP | 900,000 | $38.9M | 1.25% | −1,900,000−67.9% | Reduced |
| Catalio Capital Management, LP | 927,711 | $40.1M | 8.40% | −35,172−3.7% | Reduced |
| Barclays PLC | 933,512 | $40.3M | 0.02% | +544,674+140.1% | Added |
| Price T Rowe Associates Inc | 961,216 | $41.5M | 0.00% | −203,751−17.5% | Reduced |
| Paradigm Biocapital Advisors LP | 965,764 | $41.7M | 1.78% | +965,764 | New |
| Sofinnova Investments, Inc. | 993,093 | $42.9M | 2.92% | +258,866+35.3% | Added |
| Emerald Advisers, LLC | 1,021,257 | $44.1M | 1.62% | −124,234−10.8% | Reduced |
| Principal Financial Group Inc | 1,030,527 | $44.5M | 0.02% | −117,765−10.3% | Reduced |
| American Century Companies Inc | 1,090,134 | $47.1M | 0.03% | +62,646+6.1% | Added |
| Bank of America Corp | 1,101,509 | $47.6M | 0.00% | +154,659+16.3% | Added |
| Citigroup Inc | 1,248,505 | $53.9M | 0.04% | −153,008−10.9% | Reduced |
| Ensign Peak Advisors, Inc | 1,315,979 | $56.8M | 0.10% | −534,060−28.9% | Reduced |
| Charles Schwab Investment Management Inc | 1,331,473 | $57.5M | 0.01% | +49,244+3.8% | Added |
| Morgan Stanley | 1,342,378 | $58.0M | 0.00% | −156,241−10.4% | Reduced |
| Northern Trust Corp | 1,363,683 | $58.9M | 0.01% | +76,836+6.0% | Added |
| Lord, Abbett & Co. LLC | 1,403,741 | $60.6M | 0.20% | +545,819+63.6% | Added |
| Cormorant Asset Management, LP | 1,600,000 | $69.1M | 5.15% | −400,000−20.0% | Reduced |
| Balyasny Asset Management LLC | 1,641,620 | $70.9M | 0.16% | +841,545+105.2% | Added |
| Two Sigma Advisers, LP | 1,684,055 | $72.7M | 0.15% | +1,410,900+516.5% | Added |
| Driehaus Capital Management LLC | 1,691,213 | $73.0M | 0.58% | +190,655+12.7% | Added |
| Woodline Partners LP | 1,704,800 | $73.6M | 0.39% | +79,045+4.9% | Added |
| Pictet Asset Management Holding SA | 1,807,434 | $78.5M | 0.08% | −282,834−13.5% | Reduced |
| SC US (TTGP), Ltd. | 1,860,364 | $80.3M | 0.57% | 00.0% | Unchanged |
| Manufacturers Life Insurance Company, The | 1,891,578 | $81.7M | 0.07% | +3,815+0.2% | Added |
| Norges Bank | 1,956,654 | $84.5M | 0.01% | +711,699+57.2% | Added |
| FMR LLC | 2,027,395 | $87.5M | 0.00% | −148,404−6.8% | Reduced |
| D. E. Shaw & Co., Inc. | 2,081,253 | $89.9M | 0.09% | +1,998,104+2,403.0% | Added |
| Macquarie Group Ltd | 2,095,235 | $90.5M | 0.11% | +2,003,713+2,189.3% | Added |
| Two Sigma Investments, LP | 2,339,067 | $101.0M | 0.18% | +1,495,746+177.4% | Added |
| Laurion Capital Management LP | 2,411,248 | $104.1M | 12.02% | −566,919−19.0% | Reduced |
| Alliancebernstein L.P. | 2,470,558 | $106.7M | 0.03% | −213,588−8.0% | Reduced |
| Goldman Sachs Group Inc | 2,621,251 | $113.2M | 0.02% | +397,943+17.9% | Added |
| Invesco Ltd. | 2,801,065 | $120.9M | 0.02% | +594,902+27.0% | Added |
| UBS Group AG | 2,812,499 | $121.4M | 0.03% | +613,985+27.9% | Added |
| Geode Capital Management, LLC | 3,681,580 | $159.0M | 0.01% | +178,686+5.1% | Added |
| Frazier Life Sciences Management, L.P. | 3,800,457 | $164.1M | 6.56% | 00.0% | Unchanged |
| Capital Research Global Investors | 3,988,298 | $172.2M | 0.03% | −679,104−14.5% | Reduced |
| State Street Corp | 5,896,596 | $254.6M | 0.01% | +146,977+2.6% | Added |
| Aisling Capital Management LP | 6,068,125 | $262.0M | 72.85% | 00.0% | Unchanged |
| Farallon Capital Management, L.L.C. | 7,900,000 | $341.1M | 1.56% | +2,169,000+37.8% | Added |
| Janus Henderson Group PLC | 9,276,532 | $400.5M | 0.20% | +2,105,133+29.4% | Added |
| Kohlberg Kravis Roberts & Co. L.P. | 13,260,971 | $572.6M | 11.83% | −6,000,000−31.2% | Reduced |
| BlackRock, Inc. | 14,259,479 | $615.7M | 0.01% | +901,983+6.8% | Added |
| Vanguard Group Inc | 16,484,985 | $711.8M | 0.01% | +1,584,840+10.6% | Added |
| Viking Global Investors LPSuperinvestorViking Global Investors | 18,555,375 | $801.2M | 2.32% | −3,500,000−15.9% | Reduced |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 0 | $0 | 0.00% | −438,050−100.0% | Sold out |
| Cutter Capital Management, LP | 0 | $0 | 0.00% | −390,644−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −321,811−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −198,780−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| M28 Capital Management LP | 0 | $0 | 0.00% | −121,200−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −118,007−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −111,000−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −90,837−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −68,866−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −36,207−100.0% | Sold out |
| Schroder Investment Management Group | 0 | $0 | 0.00% | −34,741−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −34,601−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −26,323−100.0% | Sold out |
| Aristeia Capital LLC | 0 | $0 | 0.00% | −23,582−100.0% | Sold out |
| Nebula Research & Development LLC | 0 | $0 | 0.00% | −15,579−100.0% | Sold out |
| HBK Investments L P | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Rangeley Capital, LLC | 0 | $0 | 0.00% | −13,000−100.0% | Sold out |
| SIH Partners, LLLP | 0 | $0 | 0.00% | −11,974−100.0% | Sold out |
| Kazazian Asset Management, LLC | 0 | $0 | 0.00% | −11,840−100.0% | Sold out |
| Camden Capital, LLC | 0 | $0 | 0.00% | −8,500−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −6,750−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −4,492−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −965−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −383−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −359−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −125−100.0% | Sold out |
| Stephens Consulting, LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| TD Private Client Wealth LLC | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| Wolff Wiese Magana LLC | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| Global Financial Private Client, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Creative Financial Designs Inc | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Weiss Asset Management LP | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Glenmede Trust Co NA | – | – | – | – | Not filed |
| Caas Capital Management LP | – | – | – | – | Not filed |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |